Ajinomoto enters US medical foods market with Cambrooke Therapeutics acquisition

d007b1c1-fd67-4634-8a60-b76bdb1f45dearticleimage.jpg

09 Nov 2017 --- Ajinomoto Co. Inc has acquired an equity position in US medical foods company Cambrooke Therapeutics, Inc through Ajinomoto North America, Inc. (Ajina) for approximately US$64 million and made it a wholly owned subsidiary. Founded in 2000, Cambrooke develops and manufactures medical foods for patients with amino acid metabolism disorders and other customers.

It also makes products such as medical foods for patients with intractable epilepsy and low-protein foods for patients with kidney and liver diseases, as well as rolling out its product lineup outside the US in Europe and elsewhere. 

The medical nutrition innovator says it uses original ingredients to develop products that are superior to competing products in taste, digestibility and has achieved a high rate of growth exceeding 20 percent annually for the past three years.

The market for medical foods in the US is the largest in the world at US$1,750 million in 2016, with a solid compound annual growth rate (CAGR) of approximately 10 percent.

The category of foods for patients with metabolic disorders accounts for about 40 percent of this market at US$660 million and is growing at an annual rate of 10 percent, estimates Ajinomoto. 

Patients with metabolic disorders are unable to ingest regular foods and must eat only specified medical foods on a daily basis, but the palatability and lack of variety of these foods has been a major issue.

For years, Ajinomoto Co. has sold amino acids into the medical foods market as ingredients. With this acquisition, the company will make a full-scale entry into that market. 

It says that by applying its scientific knowledge of amino acids’ nutritional and physiological functions, “deliciousness technologies” and food application technologies to Cambrooke’s operations, it will offer enhanced foods to patients with metabolic disorders. 

Increase market share
In addition, by adding to the disease areas covered and using its sales channels outside Japan to strengthen Cambrooke’s overseas rollout, Ajinomoto Co. aims to expand its share of the global market for medical foods for patients with amino acid metabolism disorders to 20 percent, with sales of approximately US$90 million by 2027.

Moreover, by incorporating Cambrooke’s knowledge of the medical foods business into Ajinomoto Co.’s food-related businesses in Japan and overseas, including processed foods, healthcare foods and supplements, Ajinomoto Co. intends to expand its lineup of high-value-added health and nutrition-related products.

Ajinomoto Co. has been conducting Food Products and AminoScience businesses centered on proprietary leading-edge bioscience and fine chemical technologies that it has cultivated over many years through research based on amino acids. 

This closely follows Ajinomoto’s completion of procedures for the acquisition of all shares of Labeyrie Traiteur Surgelés S.A.S. (LTS) through its consolidate subsidiary Ajinomoto Foods Europe S.A.S. in accordance with details announced on July 20, 2017.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Health & Nutrition News

Parents uncertain about young children’s dietary transitions, IFIC survey shows

24 Sep 2018 --- A majority of parents of children under 24 months old are confident that they are feeding them an age-appropriate and nutritious diet, a survey by the International Food Information Council (IFIC) Foundation has found. However, in addition to these positive findings, the survey also uncovered parents’ underlying concerns around issues like what foods to introduce into their kids’ diets and when. The survey, funded by the US National Yogurt Association, points to the need for clear, unambiguous information on what constitutes good children’s nutrition.

Health & Nutrition News

Grabbing the opportunity: Snacking NPD undergoes health transformation

24 Sep 2018 --- Consumers are increasingly seeking food options that are suitable for on the go consumption, as well as being nutritious. Traditional fast-food snacks may fall short as healthful demands prevail, spurring ample NPD and innovation in an array of market areas. Nutrition on the go is becoming more achievable as healthier foods package themselves in on the go friendly formats, as well as established snacking options undergoing healthy transformations. 

Health & Nutrition News

Probiotic use associated with fewer antibiotic prescriptions: study

20 Sep 2018 --- Healthy infants and children who take probiotics as a preventative measure receive fewer antibiotic prescriptions, a scientific paper published in European Journal of Public Health reports. The findings are of particular interest considering the growing global demand for ways to reduce antibiotic use, given the urgent public health threat of antibiotic resistance. 

Health & Nutrition News

Nestlé to explore strategic options for Skin Health unit, reaffirms importance of Health Science division

20 Sep 2018 --- Nestlé is exploring strategic options for its Skin Health unit, after the company’s board concluded that the future growth opportunities of Nestlé Skin Health increasingly lie outside the group’s strategic scope. The company has come under increased pressure from shareholders to overhaul its strategy following disappointing 2017 results, with the company reporting its lowest sales growth in more than two decades. The strategic review is expected to be completed by mid-2019.

Health & Nutrition News

Adapting to the market? Adaptogens thrive on natural and health trends, but marketing remains a challenge

20 Sep 2018 --- Products that are clean label, natural and have health benefits are in vogue, and busy lifestyles are putting a spotlight on foods and beverages that can offer some stress relief and mood balancing effects. It’s no wonder then that adaptogens – claimed to stabilize physiological processes and promote homeostasis – are having a moment. Featured in a growing number of product categories, suppliers tip ongoing research into their capabilities as well as consumer education as necessary for continued growth.

More Articles
URL : http://www.nutritioninsight.com:80/news/ajinomoto-enters-us-medical-foods-market-with-cambrooke-therapeutics-acquisition.html